S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

ADVM Adverum Biotechnologies Inc

4.62

0.00 (0.00%)

Pre Market

Last Updated: 03:00:00

Delayed by 15 minutes

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Adverum Biotechnologies (NASDAQ:ADVM)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Adverum Biotechnologies Charts.

Adverum Biotechnologies (NASDAQ:ADVM)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Adverum Biotechnologies Charts.

Adverum Biotechnologies Inc News

Adverum Biotechnologies Initiates ARTEMIS Phase 3 Study Evaluating Ixo-vec for Wet AMD
Monday 3 March 2025 (4 days ago) • GlobeNewswire Inc.

Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Friday 28 February 2025 (7 days ago) • GlobeNewswire Inc.

Form S-8 - Securities to be offered to employees in employee benefit plans
Thursday 27 February 2025 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 27 February 2025 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 27 February 2025 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 27 February 2025 (1 week ago) • Edgar (US Regulatory)

Adverum Biotechnologies to Participate in the Cowen 45th Annual Health Care Conference
Tuesday 25 February 2025 (1 week ago) • GlobeNewswire Inc.

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 14 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Adverum Biotechnologies to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Wednesday 5 February 2025 (4 weeks ago) • GlobeNewswire Inc.

Form S-8 - Securities to be offered to employees in employee benefit plans
Thursday 19 December 2024 (3 months ago) • Edgar (US Regulatory)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Tuesday 17 December 2024 (3 months ago) • Edgar (US Regulatory)

Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Friday 6 December 2024 (3 months ago) • GlobeNewswire Inc.

More Adverum Biotechnologies Inc News Articles

Tonix Pharmaceuticals

Mullen Automotive

Accredited Solutions (PK)

RespireRx Pharmaceuticals (CE)

TPT Global Tech (PK)

Kraig Biocraft Laborator... (QB)

Impact Fusion (PK)

AMC Entertainment

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions